Renexxion plans to file new drug application (NDA) with the Food and Drug Administration (FDA) using future Phase 3 results ROSCREA, Ireland and ...
GIMOTI leverages nasal delivery to capture the expanding diabetic gastroparesis market due to growing diabetes prevalence. Its advantages over oral therapies, strong sales growth, expanding prescriber ...
Experts discuss diagnosis, diet, medications, and individualized management strategies for abdominal bloating.
A Taunton woman with two rare health conditions, leaving her oesophagus and stomach paralysed, has successfully raised enough ...
Most patients who have taken a GLP-1 received their prescription through a primary care doctor or a specialist, KFF polling ...
GLP-1 drugs like Ozempic are widely used, but muscle loss is an underreported side effect. Samsung is researching how its ...
Prescribers need to be sure the drugs will be safe and effective (Picture: Getty Images) For many Brits struggling to lose weight, drugs like Mounjaro and Wegovy have been hailed as game-changers — ...
Thousands of people hoping to access weight loss jabs are being rejected as clinics tighten screening rules. Health experts ...
In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Mary-Elizabeth Patti, MD, and ...
GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose significant weight, blood sugar improves, and for the first time in a long time, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results